Stockreport

BRIEF-Kadmon Posts Positive Topline Results From Phase 2 Study Of KD025 In Idiopathic Pulmonary Fibrosis [Reuters]

Kadmon Holdings, Inc.  (KDMN) 
Last kadmon holdings, inc. earnings: 3/5 04:14 pm Check Earnings Report
US:NYSE Investor Relations: investors.kadmon.com
PDF BRIEF-Kadmon Posts Positive Topline Results From Phase 2 Study Of KD025 In Idiopathic Pulmonary Fibrosis | Reuters Reuters Staff 1 Min Read Feb 12 (Reuters) - Kadmon Hol [Read more]